Safety of Intravenous Lidocaine Infusions for Chronic Neuropathic Pain

Lawson Health Research Institute1 个研究点分布在 1 个国家目标入组 70 人开始时间: 2009年6月最近更新: 2010年3月24日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Lawson Health Research Institute
入组人数: 70
试验地点: 1

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to prospectively determine the side effects profile in adults with neuropathic pain receiving intravenous infusions of lidocaine 5 mg per kg of lean body weight, infused over 45 minutes.

详细描述

Eligibility Criteria:

Adults > 18 yrs with chronic central or peripheral neuropathic pain at the St Joseph's Health Care Pain Clinic between June and December 2009.

Outcome measures: All side effects spontaneously reported. Sedation, nausea, dizziness by Visual Analog Score Q 15 minutes; hemodynamic data q 5 minutes during and after infusion for 30 minutes.

Daily diary of side effects and Visual Analogue score of Pain for 7 days post-infusion.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 80 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Adult outpatients > 18 years < 80 years diagnosed with chronic neuropathic pain

排除标准

•Unable to provide informed consent
•Unable to speak and understand English
•Liver, kidney, or cardiac failure
•Allergy to Lidocaine

研究者

发起方

Lawson Health Research Institute

申办方类型

Other

研究点 (1)

Loading locations...

相似试验

招募中

不适用

Lidocaine Infusion Treatment for Subarachnoid Hemorrhage HeadachesHeadacheHemorrhage, Nontraumatic Subarachnoid

NCT06582810University of Kansas Medical Center20

招募中

2 期

Intravenous Lidocaine on Chronic Pain in Patients Undergoing HepatectomyPostoperative Chronic Pain

NCT05492669West China Hospital260

招募中

不适用

Lidocaine and Magnesium and Ketamine in Gynecological SurgeryPain, PostoperativePain, AcutePain, ChronicPain, NeuropathicLidocaineKetamineMagnesiumCentral Nervous System DepressantsAnalgesicsNeurotransmitter AgentsAnalgesics, Non-narcotic

NCT04622904Aretaieion University Hospital90

终止

3 期

Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 PandemiaAcute Respiratory Distress Syndrome (ARDS)COVID-19Corona Virus Infection

NCT04609865University Hospital, Strasbourg, France14

Unknown

2 期

Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic PainDiabetic PolyneuropathyPostherpetic NeuralgiaPeripheral Neuropathy

NCT02597257Seoul National University Hospital44